0 likes | 1 Vues
Healthark conducted a comprehensive market assessment for next-gen minimally invasive surgical devices treating Abnormal Uterine Bleeding (AUB) in India, analyzing adoption barriers, pricing dynamics, and procurement behaviors through primary research with gynecologists, sales reps, and distributors. Our market sizing and revenue forecasting model segmented capital equipment and consumables, providing actionable insights on adoption scenarios to guide the clientu2019s strategic resource allocation and go-to-market planning for a successful product launch.
E N D